Statement Of Income

Medrx Co.,Ltd. - Filing #7312833

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Statement of income
Statement of income
Net sales
Net sales
231,478,000 JPY
6,963,000 JPY
Net sales of finished goods
JPY
6,963,000 JPY
Operating revenue
Operating expenses
Research and development expenses
256,291,000 JPY
360,527,000 JPY
Depreciation
1,140,000 JPY
1,167,000 JPY
Cost of sales
Cost of sales
JPY
2,400,000 JPY
Cost of finished goods sold
JPY
2,400,000 JPY
Cost of finished goods sold
Operating expenses
Selling, general and administrative expenses
367,090,000 JPY
483,190,000 JPY
Operating expenses
Operating expenses - general
Ordinary profit (loss)
-84,950,000 JPY
-480,591,000 JPY
Non-operating income
Interest income
17,000 JPY
5,000 JPY
Gross profit (loss)
231,478,000 JPY
4,563,000 JPY
Gross profit
Operating profit (loss)
-135,611,000 JPY
-478,626,000 JPY
General and administrative expenses
Selling, general and administrative expenses
Non-operating income
Non-operating income
62,441,000 JPY
6,627,000 JPY
Financial revenue
Other
8,000 JPY
499,000 JPY
Extraordinary income
20,754,000 JPY
JPY
Non-operating expenses
Non-operating expenses
11,779,000 JPY
8,592,000 JPY
Financial expenses
Share issuance costs
1,733,000 JPY
3,224,000 JPY
Profit (loss) before income taxes
-64,195,000 JPY
-480,591,000 JPY
Extraordinary income
Income taxes - current
1,731,000 JPY
1,438,000 JPY
Income taxes - deferred
-4,918,000 JPY
-72,000 JPY
General and administrative expenses
Income taxes
-3,186,000 JPY
1,366,000 JPY
Profit (loss)
-61,008,000 JPY
-481,957,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.